Literature DB >> 15378291

Expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori.

Vivi Joosten1, Robin J Gouka, Cees A M J J van den Hondel, C Theo Verrips, B Christien Lokman.   

Abstract

We report the expression and production of llama variable heavy-chain antibody fragments (V(HH)s) by Aspergillus awamori. Fragments encoding V(HH)s were cloned in a suitable Aspergillus expression vector and transformants secreting V(HH) fragments were analysed for integrated gene copy-numbers, mRNA levels and protein production. Functional V(HH)s were detected in the culture medium, indicating the feasibility of producing this type of protein in a fungal expression system. Secreted V(HH)s were subjected to (extracellular) degradation, which could be partially prevented by the addition of BSA to the culture medium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378291     DOI: 10.1007/s00253-004-1689-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

1.  High-level expression of Camelid nanobodies in Nicotiana benthamiana.

Authors:  Yi-Hui Audrey Teh; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2009-10-28       Impact factor: 2.788

2.  Extracellular Expression in Aspergillus niger of an Antibody Fused to Leishmania sp. Antigens.

Authors:  Denis Magaña-Ortíz; Francisco Fernández; Achim M Loske; Miguel A Gómez-Lim
Journal:  Curr Microbiol       Date:  2017-08-31       Impact factor: 2.188

3.  Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.

Authors:  Laura E McCoy; Anna Forsman Quigley; Nika M Strokappe; Bianca Bulmer-Thomas; Michael S Seaman; Daniella Mortier; Lucy Rutten; Nikita Chander; Carolyn J Edwards; Robin Ketteler; David Davis; Theo Verrips; Robin A Weiss
Journal:  J Exp Med       Date:  2012-05-28       Impact factor: 14.307

4.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

Review 5.  Nanobodies to Study G Protein-Coupled Receptor Structure and Function.

Authors:  Aashish Manglik; Brian K Kobilka; Jan Steyaert
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-12-07       Impact factor: 13.820

6.  A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo.

Authors:  Yan Yan; Xiao Cheng; Lin Li; Rumeng Zhang; Yong Zhu; Zhengsheng Wu; Keshuo Ding
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

7.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

Review 8.  Anti-SARS-CoV-1 and -2 nanobody engineering towards avidity-inspired therapeutics.

Authors:  Eugene M Obeng; Christian K O Dzuvor; Michael K Danquah
Journal:  Nano Today       Date:  2021-11-23       Impact factor: 20.722

9.  Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice.

Authors:  Song Liu; Guanghui Li; Lei Ding; Jin Ding; Qian Zhang; Dan Li; Xingguo Hou; Xiangxing Kong; Jing Zou; Shiming Zhang; Hongbin Han; Yakun Wan; Zhi Yang; Hua Zhu
Journal:  Research (Wash D C)       Date:  2022-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.